Yammine, Luba <br/><br/>
Cigarette smoking, type 2 diabetes mellitus, and glucagon-like peptide-1 receptor agonists as a potential treatment for smokers with diabetes: An integrative review.  [electronic resource] 

 -  Diabetes research and clinical practice  Mar 2019 
 - 78-88 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1872-8227 
<br/><br/><label>Standard No.: </label>10.1016/j.diabres.2019.01.033  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cigarette Smoking--adverse effects<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Glucagon-Like Peptide 1--agonists<br/>Glucagon-Like Peptide-1 Receptor--therapeutic use<br/>Humans<br/>Hypoglycemic Agents--pharmacology